Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Concha Labs is a private U.S. hearing technology company developing and commercializing personalized over-the-counter hearing solutions for adults with mild to moderate hearing loss. Its flagship commercial product is Concha Sol hearing aids, which use the company\u2019s patented Soundscope personalization technology and companion software to self-fit hearing profiles based on real-world speech-in-noise performance. The company positions its offering as an FDA-cleared, clinically validated alternative to traditional clinician-fitted hearing aids, with published results from a University of Minnesota-led study in Trends in Hearing. Concha Labs combines medical device hardware, psychoacoustic personalization, and app-based software to improve speech clarity while reducing time, cost, and friction in hearing care access. The business appears focused on consumer hearing health rather than therapeutics or drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Concha Labs.